Basiliximab Unknown Status Phase 3 Trials for Transplantation, Kidney / Ischemia-Reperfusion Injury Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01239563Thymoglobulin Induction in Kidney Transplant Recipients